Industry
Visitors to booth #3C88 in Barcelona this May can explore how dsm-firmenich is unlocking increased health expectancy with the latest science-backed innovations targeting the cellular hallmarks of aging.
Industry
CHMP has announced the development of a dedicated reflection paper on the non-clinical development and evaluation of microbiome-based medicinal products (MMPs).
How postbiotics are reshaping dietary supplements and pharma: key insights from Humiome® Post LB.
Industry
MaaT Pharma, based in Lyon and listed on Euronext Paris, unveiled the final results of its ARES Phase 3 trial of Xervyteg® (MaaT013).
Industry
New IPA Europe analysis puts hard numbers on how evidence-based probiotic use could cut healthcare costs and boost productivity across the EU.
Industry
2 December event in Brussels will unveil new socio-economic analysis on how clearer EU rules for probiotics could cut healthcare costs, drive innovation and strengthen the single market.
Bifidobacterium breve 2TA, Lacticaseibacillus rhamnosus L13B, and Lactobacillus gasseri L6 are not just bacteria: they are witnesses to the intimate, ancestral dialogue between mothers, infants, and microbes.
Through this collaboration, the Icelandic tradition of dairy innovation merges with Italian scientific expertise to drive the future of functional nutrition.
Industry
At the 67th ASH, one of hematology’s biggest stages, the Lyon-based biotech will present pivotal Phase 3 results that can bend treatment paradigms.
ProBeautyShield by SynBalance is an innovative probiotic complex developed to support and protect skin health.